The Experts below are selected from a list of 360 Experts worldwide ranked by ideXlab platform
Catherine Williamson - One of the best experts on this subject based on the ideXlab platform.
-
Gender Equity programmes in academic medicine a realist evaluation approach to athena swan processes
BMJ Open, 2016Co-Authors: Catherine Williamson, Louise Caffrey, David Wyatt, Nina Fudge, Helena Mattingley, Christopher MckevittAbstract:Objectives Gender inEquity has persisted in academic medicine. Yet Equity is vital for countries to achieve their full potential in terms of translational research and patient benefit. This study sought to understand how the Gender Equity programme, Athena SWAN, can be enabled and constrained by interactions between the programme and the context it is implemented into, and whether these interactions might produce unintended consequences. Design Multimethod qualitative case studies using a realist evaluation approach. Setting 5 departments from a university medical school hosting a Translational Research Organisation. Participants 25 hours of observations of Gender equality committee meetings, 16 in-depth interviews with Heads of Departments, Committee Leads and key personnel involved in the initiative. 4 focus groups with 15 postdoctoral researchers, lecturers and senior lecturers. Results The implementation of Athena SWAN principles was reported to have created social space to address Gender inEquity and to have highlighted problematic practices to staff. However, a number of factors reduced the programme's potential to impact Gender inEquity. Gender inEquity was reproduced in the programme's enactment as female staff was undertaking a disproportionate amount of Athena SWAN work, with potential negative impacts on individual women's career progression. Early career researchers experienced problems accessing Athena SWAN initiatives. Furthermore, the impact of the programme was perceived to be undermined by wider institutional practices, national policies and societal norms, which are beyond the programme's remit. Conclusions Gender Equity programmes have the potential to address inEquity. However, paradoxically, they can also unintentionally reproduce and reinforce Gender inEquity through their enactment. Potential programme impacts may be undermined by barriers to staff availing of career development and training initiatives, and by wider institutional practices, national policies and societal norms.
-
markers of achievement for assessing and monitoring Gender Equity in translational research organisations a rationale and study protocol
BMJ Open, 2016Co-Authors: Pavel V Ovseiko, Laurel D Edmunds, Linda H Pololi, Vasiliki Kiparoglou, Lorna R Henderson, Catherine Williamson, Jonathan Grant, Trisha Greenhalgh, Graham M LordAbstract:Introduction Translational research organisations (TROs) are a core component of the UK9s expanding research base. Equity of career opportunity is key to ensuring a diverse and internationally competitive workforce. The UK now requires TROs to demonstrate how they are supporting Gender Equity. Yet, the evidence base for documenting such efforts is sparse. This study is designed to inform the acceleration of women9s advancement and leadership in two of the UK9s leading TROs—the National Institute for Health Research (NIHR) Biomedical Research Centres (BRCs) in Oxford and London—through the development, application and dissemination of a conceptual framework and measurement tool. Methods and analysis A cross-sectional retrospective evaluation. A conceptual framework with markers of achievement and corresponding candidate metrics has been specifically designed for this study based on an adapted balanced scorecard approach. It will be refined with an online stakeholder consultation and semistructured interviews to test the face validity and explore practices and mechanisms that influence Gender Equity in the given settings. Data will be collected via the relevant administrative databases. A comparison of two funding periods (2007–2012 and 2012–2017) will be carried out. Ethics and dissemination The University of Oxford Clinical Trials and Research Governance Team and the Research and Development Governance Team of Guy9s and St Thomas’ National Health Service (NHS) Foundation Trust reviewed the study and deemed it exempt from full ethics review. The results of the study will be used to inform prospective planning and monitoring within the participating NIHR BRCs with a view to accelerating women9s advancement and leadership. Both the results of the study and its methodology will be further disseminated to academics and practitioners through the networks of collaborating TROs, relevant conferences and articles in peer-reviewed journals.
-
markers of achievement for assessing and monitoring Gender Equity in translational research organisations a rationale and study protocol
BMJ Open, 2016Co-Authors: Pavel V Ovseiko, Laurel D Edmunds, Linda H Pololi, Vasiliki Kiparoglou, Lorna R Henderson, Catherine Williamson, Jonathan Grant, Trisha Greenhalgh, Graham M LordAbstract:Introduction Translational research organisations (TROs) are a core component of the UK9s expanding research base. Equity of career opportunity is key to ensuring a diverse and internationally competitive workforce. The UK now requires TROs to demonstrate how they are supporting Gender Equity. Yet, the evidence base for documenting such efforts is sparse. This study is designed to inform the acceleration of women9s advancement and leadership in two of the UK9s leading TROs—the National Institute for Health Research (NIHR) Biomedical Research Centres (BRCs) in Oxford and London—through the development, application and dissemination of a conceptual framework and measurement tool. Methods and analysis A cross-sectional retrospective evaluation. A conceptual framework with markers of achievement and corresponding candidate metrics has been specifically designed for this study based on an adapted balanced scorecard approach. It will be refined with an online stakeholder consultation and semistructured interviews to test the face validity and explore practices and mechanisms that influence Gender Equity in the given settings. Data will be collected via the relevant administrative databases. A comparison of two funding periods (2007–2012 and 2012–2017) will be carried out. Ethics and dissemination The University of Oxford Clinical Trials and Research Governance Team and the Research and Development Governance Team of Guy9s and St Thomas’ National Health Service (NHS) Foundation Trust reviewed the study and deemed it exempt from full ethics review. The results of the study will be used to inform prospective planning and monitoring within the participating NIHR BRCs with a view to accelerating women9s advancement and leadership. Both the results of the study and its methodology will be further disseminated to academics and practitioners through the networks of collaborating TROs, relevant conferences and articles in peer-reviewed journals.
Graham M Lord - One of the best experts on this subject based on the ideXlab platform.
-
markers of achievement for assessing and monitoring Gender Equity in translational research organisations a rationale and study protocol
BMJ Open, 2016Co-Authors: Pavel V Ovseiko, Laurel D Edmunds, Linda H Pololi, Vasiliki Kiparoglou, Lorna R Henderson, Catherine Williamson, Jonathan Grant, Trisha Greenhalgh, Graham M LordAbstract:Introduction Translational research organisations (TROs) are a core component of the UK9s expanding research base. Equity of career opportunity is key to ensuring a diverse and internationally competitive workforce. The UK now requires TROs to demonstrate how they are supporting Gender Equity. Yet, the evidence base for documenting such efforts is sparse. This study is designed to inform the acceleration of women9s advancement and leadership in two of the UK9s leading TROs—the National Institute for Health Research (NIHR) Biomedical Research Centres (BRCs) in Oxford and London—through the development, application and dissemination of a conceptual framework and measurement tool. Methods and analysis A cross-sectional retrospective evaluation. A conceptual framework with markers of achievement and corresponding candidate metrics has been specifically designed for this study based on an adapted balanced scorecard approach. It will be refined with an online stakeholder consultation and semistructured interviews to test the face validity and explore practices and mechanisms that influence Gender Equity in the given settings. Data will be collected via the relevant administrative databases. A comparison of two funding periods (2007–2012 and 2012–2017) will be carried out. Ethics and dissemination The University of Oxford Clinical Trials and Research Governance Team and the Research and Development Governance Team of Guy9s and St Thomas’ National Health Service (NHS) Foundation Trust reviewed the study and deemed it exempt from full ethics review. The results of the study will be used to inform prospective planning and monitoring within the participating NIHR BRCs with a view to accelerating women9s advancement and leadership. Both the results of the study and its methodology will be further disseminated to academics and practitioners through the networks of collaborating TROs, relevant conferences and articles in peer-reviewed journals.
-
markers of achievement for assessing and monitoring Gender Equity in translational research organisations a rationale and study protocol
BMJ Open, 2016Co-Authors: Pavel V Ovseiko, Laurel D Edmunds, Linda H Pololi, Vasiliki Kiparoglou, Lorna R Henderson, Catherine Williamson, Jonathan Grant, Trisha Greenhalgh, Graham M LordAbstract:Introduction Translational research organisations (TROs) are a core component of the UK9s expanding research base. Equity of career opportunity is key to ensuring a diverse and internationally competitive workforce. The UK now requires TROs to demonstrate how they are supporting Gender Equity. Yet, the evidence base for documenting such efforts is sparse. This study is designed to inform the acceleration of women9s advancement and leadership in two of the UK9s leading TROs—the National Institute for Health Research (NIHR) Biomedical Research Centres (BRCs) in Oxford and London—through the development, application and dissemination of a conceptual framework and measurement tool. Methods and analysis A cross-sectional retrospective evaluation. A conceptual framework with markers of achievement and corresponding candidate metrics has been specifically designed for this study based on an adapted balanced scorecard approach. It will be refined with an online stakeholder consultation and semistructured interviews to test the face validity and explore practices and mechanisms that influence Gender Equity in the given settings. Data will be collected via the relevant administrative databases. A comparison of two funding periods (2007–2012 and 2012–2017) will be carried out. Ethics and dissemination The University of Oxford Clinical Trials and Research Governance Team and the Research and Development Governance Team of Guy9s and St Thomas’ National Health Service (NHS) Foundation Trust reviewed the study and deemed it exempt from full ethics review. The results of the study will be used to inform prospective planning and monitoring within the participating NIHR BRCs with a view to accelerating women9s advancement and leadership. Both the results of the study and its methodology will be further disseminated to academics and practitioners through the networks of collaborating TROs, relevant conferences and articles in peer-reviewed journals.
Anita Raj - One of the best experts on this subject based on the ideXlab platform.
-
making the continuum of care work for mothers and infants does Gender Equity matter findings from a quasi experimental study in bihar india
PLOS ONE, 2017Co-Authors: Lotus Mcdougal, Jay G Silverman, Yamini Atmavilas, Katherine Hay, Usha Kiran Tarigopula, Anita RajAbstract:Background Improvements in continuum of care (CoC) utilization are needed to address inadequate reductions in neonatal and infant mortality in India and elsewhere. This study examines the effect of Ananya, a health system training and community outreach intervention, on reproductive, maternal and newborn health continuum of care (RMNH CoC) utilization in Bihar, India, and explores whether that effect is moderated by Gender Equity factors (child marriage, restricted mobility and low decision-making control). Methods A two-armed quasi-experimental design compared districts in Bihar that did/did not implement Ananya. Cross-sections of married women aged 15–49 with a 0–5 month old child were surveyed at baseline and two year follow-up (baseline n = 7191 and follow-up n = 6143; response rates 88.9% and 90.7%, respectively). Difference-in-difference analyses assessed program impact on RMNH CoC co-coverage, defined by 9 health services/behaviors for the index pregnancy (e.g., antenatal care, skin-to-skin care). Three-way interactions assessed Gender Equity as a moderator of Ananya’s impact. Findings Participants reported low RMNH CoC co-coverage at baseline (on average 3.2 and 3.0 of the 9 RMNH services/behaviors for Ananya and control groups, respectively). The Ananya group showed a significantly greater increase in RMNH CoC co-coverage (.41 services) compared with the control group over time (p<0.001), with the primary drivers being increases in clean cord care, skin-to-skin care and postpartum contraceptive use. Gender Equity interaction analyses revealed diminished intervention effects on antenatal care, skilled birth attendance and exclusive breastfeeding for women married as minors. Conclusion Ananya improved RMNH CoC co-coverage among these recent mothers, largely through positive health behavior changes. Child marriage attenuated Ananya’s impact on utilization of key health services and behaviors. Supporting the health system with training and community outreach can be beneficial to RMNH CoC utilization; additional support is needed to adequately address the unique issues faced by women married as minors.
-
cluster randomized controlled trial evaluation of a Gender Equity and family planning intervention for married men and couples in rural india
PLOS ONE, 2016Co-Authors: Anita Raj, Jay G Silverman, Mohan Ghule, Julie Ritter, Madhusudana Battala, Saritha Nair, Anindita Dasgupta, Donta Balaiah, Velhal Gajanan, Niranjan SaggurtiAbstract:Background Despite ongoing recommendations to increase male engagement and Gender-Equity (GE) counseling in family planning (FP) services, few such programs have been implemented and rigorously evaluated. This study evaluates the impact of CHARM, a three-session GE+FP counseling intervention delivered by male health care providers to married men, alone (sessions 1&2) and with their wives (session 3) in India. Methods and Findings A two-armed cluster randomized controlled trial was conducted with young married couples (N = 1081 couples) recruited from 50 geographic clusters (25 clusters randomized to CHARM and a control condition, respectively) in rural Maharashtra, India. Couples were surveyed on demographics, contraceptive behaviors, and intimate partner violence (IPV) attitudes and behaviors at baseline and 9 &18-month follow-ups, with pregnancy testing at baseline and 18-month follow-up. Outcome effects on contraceptive use and incident pregnancy, and secondarily, on contraceptive communication and men’s IPV attitudes and behaviors, were assessed using logistic generalized linear mixed models. Most men recruited from CHARM communities (91.3%) received at least one CHARM intervention session; 52.5% received the couple’s session with their wife. Findings document that women from the CHARM condition, relative to controls, were more likely to report contraceptive communication at 9-month follow-up (AOR = 1.77, p = 0.04) and modern contraceptive use at 9 and 18-month follow-ups (AORs = 1.57–1.58, p = 0.05), and they were less likely to report sexual IPV at 18-month follow-up (AOR = 0.48, p = 0.01). Men in the CHARM condition were less likely than those in the control clusters to report attitudes accepting of sexual IPV at 9-month (AOR = 0.64, p = 0.03) and 18-month (AOR = 0.51, p = 0.004) follow-up, and attitudes accepting of physical IPV at 18-month follow-up (AOR = 0.64, p = 0.02). No significant effect on pregnancy was seen. Conclusions Findings demonstrate that men can be engaged in FP programming in rural India, and that such an approach inclusive of GE counseling can improve contraceptive practices and reduce sexual IPV in married couples. Trial Registration ClinicalTrials.gov NCT01593943
-
charm a Gender Equity and family planning intervention for men and couples in rural india protocol for the cluster randomized controlled trial evaluation
Reproductive Health, 2016Co-Authors: Jennifer Yore, Jay G Silverman, Mohan Ghule, Madhusudana Battala, Saritha Nair, Anindita Dasgupta, Niranjan Saggurti, Donta Balaiah, Anita RajAbstract:Globally, 41 % of all pregnancies are unintended, increasing risk for unsafe abortion, miscarriage and maternal and child morbidities and mortality. One in four pregnancies in India (3.3 million pregnancies, annually) are unintended; 2/3 of these occur in the context of no modern contraceptive use. In addition, no contraceptive use until desired number and sex composition of children is achieved remains a norm in India. Research shows that globally and in India, the youngest and most newly married wives are least likely to use contraception and most likely to report husband’s exclusive family planning decision-making control, suggesting that male engagement and family planning support is important for this group. Thus, the Counseling Husbands to Achieve Reproductive Health and Marital Equity (CHARM) intervention was developed in recognition of the need for more male engagement family planning models that include Gender Equity counseling and focus on spacing contraception use in rural India. For this study, a multi-session intervention delivered to men but inclusive of their wives was developed and evaluated as a two-armed cluster randomized controlled design study conducted across 50 mapped clusters in rural Maharashtra, India. Eligible rural young husbands and their wives (N = 1081) participated in a three session Gender-Equity focused family planning program delivered to the men (Sessions 1 and 2) and their wives (Session 3) by village health providers in rural India. Survey assessments were conducted at baseline and 9&18 month follow-ups with eligible men and their wives, and pregnancy tests were obtained from wives at baseline and 18-month follow-up. Additional in-depth understanding of how intervention impact occurred was assessed via in-depth interviews at 18 month follow-up with VHPs and a subsample of couples (n = 50, 2 couples per intervention cluster). Process evaluation was conducted to collect feedback from husbands, wives, and VHPs on program quality and to ascertain whether program elements were implemented according to curriculum protocols. Fidelity to intervention protocol was assessed via review of clinical records. All study procedures were completed in February 2015. Findings from this work offer important contributions to the growing field of male engagement in family planning, globally. ClinicalTrial.gov, NCT01593943
-
charm a Gender Equity and family planning intervention for men and couples in rural india protocol for the cluster randomized controlled trial evaluation
Reproductive Health, 2016Co-Authors: Jennifer Yore, Jay G Silverman, Mohan Ghule, Madhusudana Battala, Saritha Nair, Anindita Dasgupta, Niranjan Saggurti, Donta Balaiah, Anita RajAbstract:Globally, 41 % of all pregnancies are unintended, increasing risk for unsafe abortion, miscarriage and maternal and child morbidities and mortality. One in four pregnancies in India (3.3 million pregnancies, annually) are unintended; 2/3 of these occur in the context of no modern contraceptive use. In addition, no contraceptive use until desired number and sex composition of children is achieved remains a norm in India. Research shows that globally and in India, the youngest and most newly married wives are least likely to use contraception and most likely to report husband’s exclusive family planning decision-making control, suggesting that male engagement and family planning support is important for this group. Thus, the Counseling Husbands to Achieve Reproductive Health and Marital Equity (CHARM) intervention was developed in recognition of the need for more male engagement family planning models that include Gender Equity counseling and focus on spacing contraception use in rural India.
Pavel V Ovseiko - One of the best experts on this subject based on the ideXlab platform.
-
a survey to explore new markers of achievement to assess and monitor Gender Equity in an nihr biomedical research centre a two factor model
medRxiv, 2020Co-Authors: L R Henderson, Pavel V Ovseiko, Alastair M Buchan, H Mcshane, Vasiliki KiparoglouAbstract:Background: The underrepresentation of women in academic medicine at senior level and in leadership positions is well documented. In the United Kingdom, the National Institute for Health Research (NIHR) announced that eligibility for funding for Biomedical Research Centres (BRCs) required at least Silver award status of the Athena SWAN Charter. However, the evidence base for monitoring Gender Equity (GE) in BRCs is underdeveloped. Methods: An exploratory online survey distributed to an entire population of NIHR Oxford BRC affiliates (N=683) who ranked the importance of 13 markers of GE on a five point Likert scale. Data were summarised using frequencies and descriptive statistics. Interrelationships between the markers and underlying latent dimensions (factors) were determined by exploratory and confirmatory factor analyses. Thematic analysis was used to analyse open-ended comments. Results: The response rate was 36% (243 respondents). Respondents were more frequently female (55%, n=133), aged 41-50 years (33%, n=81), investigators (33%, n=81) and had been affiliated with the BRC for 2-7 years (39.5%, n=96). Participants ranked BRC senior leadership roles and organisational policies on Gender Equity, as very important, 58% (n=141) and 57% (n=139) respectively. The top two markers ranked as very important by female participants were organisational policies (64.7%, n=86/133) and recruitment and retention (60.9%, n=81/133), whereas male participants ranked leadership development (52.1%, n=50/96) and BRC senior leadership roles (50%, n=48/96) as being very important. The factor analyses showed two distinct latent dimensions: organisational markers and individual markers of GE in BRCs. Open ended comments suggested three key areas of actions: monitoring and benchmarking, organisational support for those with childcare responsibilities, and leadership and Institutional support for GE. Conclusions: The findings suggest a two-factor model of markers of achievement for GE with organisational and individual dimensions. Implementation and sustainability of Gender Equity requires commitment at senior leadership and organisational policy level.
-
markers of achievement for assessing and monitoring Gender Equity in translational research organisations a rationale and study protocol
BMJ Open, 2016Co-Authors: Pavel V Ovseiko, Laurel D Edmunds, Linda H Pololi, Vasiliki Kiparoglou, Lorna R Henderson, Catherine Williamson, Jonathan Grant, Trisha Greenhalgh, Graham M LordAbstract:Introduction Translational research organisations (TROs) are a core component of the UK9s expanding research base. Equity of career opportunity is key to ensuring a diverse and internationally competitive workforce. The UK now requires TROs to demonstrate how they are supporting Gender Equity. Yet, the evidence base for documenting such efforts is sparse. This study is designed to inform the acceleration of women9s advancement and leadership in two of the UK9s leading TROs—the National Institute for Health Research (NIHR) Biomedical Research Centres (BRCs) in Oxford and London—through the development, application and dissemination of a conceptual framework and measurement tool. Methods and analysis A cross-sectional retrospective evaluation. A conceptual framework with markers of achievement and corresponding candidate metrics has been specifically designed for this study based on an adapted balanced scorecard approach. It will be refined with an online stakeholder consultation and semistructured interviews to test the face validity and explore practices and mechanisms that influence Gender Equity in the given settings. Data will be collected via the relevant administrative databases. A comparison of two funding periods (2007–2012 and 2012–2017) will be carried out. Ethics and dissemination The University of Oxford Clinical Trials and Research Governance Team and the Research and Development Governance Team of Guy9s and St Thomas’ National Health Service (NHS) Foundation Trust reviewed the study and deemed it exempt from full ethics review. The results of the study will be used to inform prospective planning and monitoring within the participating NIHR BRCs with a view to accelerating women9s advancement and leadership. Both the results of the study and its methodology will be further disseminated to academics and practitioners through the networks of collaborating TROs, relevant conferences and articles in peer-reviewed journals.
-
markers of achievement for assessing and monitoring Gender Equity in translational research organisations a rationale and study protocol
BMJ Open, 2016Co-Authors: Pavel V Ovseiko, Laurel D Edmunds, Linda H Pololi, Vasiliki Kiparoglou, Lorna R Henderson, Catherine Williamson, Jonathan Grant, Trisha Greenhalgh, Graham M LordAbstract:Introduction Translational research organisations (TROs) are a core component of the UK9s expanding research base. Equity of career opportunity is key to ensuring a diverse and internationally competitive workforce. The UK now requires TROs to demonstrate how they are supporting Gender Equity. Yet, the evidence base for documenting such efforts is sparse. This study is designed to inform the acceleration of women9s advancement and leadership in two of the UK9s leading TROs—the National Institute for Health Research (NIHR) Biomedical Research Centres (BRCs) in Oxford and London—through the development, application and dissemination of a conceptual framework and measurement tool. Methods and analysis A cross-sectional retrospective evaluation. A conceptual framework with markers of achievement and corresponding candidate metrics has been specifically designed for this study based on an adapted balanced scorecard approach. It will be refined with an online stakeholder consultation and semistructured interviews to test the face validity and explore practices and mechanisms that influence Gender Equity in the given settings. Data will be collected via the relevant administrative databases. A comparison of two funding periods (2007–2012 and 2012–2017) will be carried out. Ethics and dissemination The University of Oxford Clinical Trials and Research Governance Team and the Research and Development Governance Team of Guy9s and St Thomas’ National Health Service (NHS) Foundation Trust reviewed the study and deemed it exempt from full ethics review. The results of the study will be used to inform prospective planning and monitoring within the participating NIHR BRCs with a view to accelerating women9s advancement and leadership. Both the results of the study and its methodology will be further disseminated to academics and practitioners through the networks of collaborating TROs, relevant conferences and articles in peer-reviewed journals.
Linda H Pololi - One of the best experts on this subject based on the ideXlab platform.
-
markers of achievement for assessing and monitoring Gender Equity in translational research organisations a rationale and study protocol
BMJ Open, 2016Co-Authors: Pavel V Ovseiko, Laurel D Edmunds, Linda H Pololi, Vasiliki Kiparoglou, Lorna R Henderson, Catherine Williamson, Jonathan Grant, Trisha Greenhalgh, Graham M LordAbstract:Introduction Translational research organisations (TROs) are a core component of the UK9s expanding research base. Equity of career opportunity is key to ensuring a diverse and internationally competitive workforce. The UK now requires TROs to demonstrate how they are supporting Gender Equity. Yet, the evidence base for documenting such efforts is sparse. This study is designed to inform the acceleration of women9s advancement and leadership in two of the UK9s leading TROs—the National Institute for Health Research (NIHR) Biomedical Research Centres (BRCs) in Oxford and London—through the development, application and dissemination of a conceptual framework and measurement tool. Methods and analysis A cross-sectional retrospective evaluation. A conceptual framework with markers of achievement and corresponding candidate metrics has been specifically designed for this study based on an adapted balanced scorecard approach. It will be refined with an online stakeholder consultation and semistructured interviews to test the face validity and explore practices and mechanisms that influence Gender Equity in the given settings. Data will be collected via the relevant administrative databases. A comparison of two funding periods (2007–2012 and 2012–2017) will be carried out. Ethics and dissemination The University of Oxford Clinical Trials and Research Governance Team and the Research and Development Governance Team of Guy9s and St Thomas’ National Health Service (NHS) Foundation Trust reviewed the study and deemed it exempt from full ethics review. The results of the study will be used to inform prospective planning and monitoring within the participating NIHR BRCs with a view to accelerating women9s advancement and leadership. Both the results of the study and its methodology will be further disseminated to academics and practitioners through the networks of collaborating TROs, relevant conferences and articles in peer-reviewed journals.
-
markers of achievement for assessing and monitoring Gender Equity in translational research organisations a rationale and study protocol
BMJ Open, 2016Co-Authors: Pavel V Ovseiko, Laurel D Edmunds, Linda H Pololi, Vasiliki Kiparoglou, Lorna R Henderson, Catherine Williamson, Jonathan Grant, Trisha Greenhalgh, Graham M LordAbstract:Introduction Translational research organisations (TROs) are a core component of the UK9s expanding research base. Equity of career opportunity is key to ensuring a diverse and internationally competitive workforce. The UK now requires TROs to demonstrate how they are supporting Gender Equity. Yet, the evidence base for documenting such efforts is sparse. This study is designed to inform the acceleration of women9s advancement and leadership in two of the UK9s leading TROs—the National Institute for Health Research (NIHR) Biomedical Research Centres (BRCs) in Oxford and London—through the development, application and dissemination of a conceptual framework and measurement tool. Methods and analysis A cross-sectional retrospective evaluation. A conceptual framework with markers of achievement and corresponding candidate metrics has been specifically designed for this study based on an adapted balanced scorecard approach. It will be refined with an online stakeholder consultation and semistructured interviews to test the face validity and explore practices and mechanisms that influence Gender Equity in the given settings. Data will be collected via the relevant administrative databases. A comparison of two funding periods (2007–2012 and 2012–2017) will be carried out. Ethics and dissemination The University of Oxford Clinical Trials and Research Governance Team and the Research and Development Governance Team of Guy9s and St Thomas’ National Health Service (NHS) Foundation Trust reviewed the study and deemed it exempt from full ethics review. The results of the study will be used to inform prospective planning and monitoring within the participating NIHR BRCs with a view to accelerating women9s advancement and leadership. Both the results of the study and its methodology will be further disseminated to academics and practitioners through the networks of collaborating TROs, relevant conferences and articles in peer-reviewed journals.